HPSE2 and breast carcinoma: Based on our results, effective and targeted therapy for patients with different breast cancer subtypes can be designed and optimized for clinical application to more precisely identify and attack cancer cells by selectively inhibiting the expression of MMP11 or inducing the expression of HPSE2.